video

R&D

Paul Hasting and Jonah Comstock interview at JP Morgan 2025

JP Morgan Week 2025 – Paul Hastings

At JP Morgan last month, pharmaphorum caught up with Paul Hastings, the CEO of Nkarta, to talk about NK cells and autoimmune diseases.

Digital

JP Morgan Week 2025 – Phil Johnson

Phil Johnson chat about why he joined Evidation and his excitement about the company’s mission.

Patients

Jonah Comstock interview at JPM25 with Rick Stewart

JP Morgan Week 2025 – Rick Stewart

At JPM Week 2025 in San Francisco, pharmaphorum editor-in-chief Jonah Comstock met with Rick Stewart, CEO of Achieve Life Sciences.

R&D

JPM25 Steve Pakola interview with Jonah Comstock

JP Morgan Week 2025 – Steve Pakola

On the sidelines of JP Morgan in San Francisco, editor-in-chief Jonah Comstock caught up with Steven Pakola, REGENXBIO’s chief medical officer.

Oncology

Jonah Comstock interview with Marianne De Backer

JP Morgan Week 2025 – Marianne De Backer

At JPM 2025, pharmaphorum editor-in-chief Jonah Comstock spoke with Vir Biotechnology CEO Marianne De Backer.

Digital

In conversation at Veeva Summit: Jonathan Crowther, Pfizer

At the Veeva Commercial Summit in Madrid at the end of 2024, pharmaphorum web editor Nicole Raleigh sat down with Pfizer’s head of predictive analytics, Jonathan Crowther, to discuss the ro